Scott H Bunner

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Affordable Care Act

Chronic Obstructive Pulmonary Disease

Peritoneal Dialysis

Clinical Practice

Top Venues

International journal of chronic obstructive pulmonary disease

This page only lists publications with an associated author ORCID identifier.

Publications

Michael Bogart, Lindsay G S Bengtson, Mary G Johnson, Scott H Bunner, Noelle N Gronroos, Kristi K DiRocco
Outcomes Following Initiation of Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol versus Multiple-Inhaler Triple Therapy Among Medicare Advantage with Part D Beneficiaries and Those Commercially Enrolled for Health Care Insurance in the United States. International journal of chronic obstructive pulmonary disease 19 (2024)
Michael Bogart, Lindsay G S Bengtson, Mary G Johnson, Scott H Bunner, Noelle N Gronroos, Kristi K DiRocco
Outcomes Following Initiation of Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol versus Multiple-Inhaler Triple Therapy Among Medicare Advantage with Part D Beneficiaries and Those Commercially Enrolled for Health Care Insurance in the United States. International journal of chronic obstructive pulmonary disease 19 (2024)
Nicola Alexander Hanania, Scott H Bunner, Lindsay G S Bengtson, Afisi S Ismaila, Michael Bogart
COPD Exacerbations, Costs, and Health Care Resource Utilization Before and After Initiation of Fluticasone Furoate/Umeclidinium/Vilanterol in Routine Care in the USA. International journal of chronic obstructive pulmonary disease 18 (2023)
Nicola Alexander Hanania, Scott H Bunner, Lindsay G S Bengtson, Afisi S Ismaila, Michael Bogart
COPD Exacerbations, Costs, and Health Care Resource Utilization Before and After Initiation of Fluticasone Furoate/Umeclidinium/Vilanterol in Routine Care in the USA. International journal of chronic obstructive pulmonary disease 18 (2023)
Nicola Alexander Hanania, Scott H Bunner, Lindsay G S Bengtson, Afisi S Ismaila, Michael Bogart
COPD Exacerbations, Costs, and Health Care Resource Utilization Before and After Initiation of Fluticasone Furoate/Umeclidinium/Vilanterol in Routine Care in the USA. International journal of chronic obstructive pulmonary disease 18 (2023)